Alzheimer Disease
Kurve Technology reports clinical success in Alzheimer disease study
Published in Diabetes Week, October 23rd, 2006
In a recent study presented at the International Conference on Alzheimer's Disease by investigators from the [U.S.] Veterans Affairs (VA) Puget Sound Health Care System in Seattle, Washington and the University of Washington School of Medicine, ViaNase intranasally delivered insulin or placebo to 24 study participants. Treatment was well-tolerated, with no serious adverse events or changes in plasma glucose or insulin...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Diabetes Week
Source: Diabetes Week (2006-10-23)
More Articles from Diabetes Week
- Diabetes Complications
Diabetes raises adverse neurocognitive outcome after coronary artery bypass grafting surgery - Diabetes Control
Caloric restriction ameliorates oxidative and inflammatory effects of diabetes in the brain - Diabetes Prevention
Peroxisome proliferator-activated receptor-alpha agonism prevents type 2 diabetes - Diabetic Nephropathy
Angiotensin II-dependent Src and Smad1 signaling pathway is key to diabetic nephropathy - Insulin Resistance
Insulin resistance accelerates muscle wasting by activation of ubiquitin-proteasome pathway - Alzheimer Disease
In Alzheimer disease, beta-amyloid toxicity may be mediated by oxidation of GRX-1 and TRX-1 - More from this issue of Diabetes Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
